The Benefits of Clinical Trials for Triple Negative Breast Cancer

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Minetta C. Liu, MD

Professor and Research Chair, Division of Medical Oncology, Department of Oncology, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Medical Director, Office of Specialty Collaborations and Contracts, Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine, Mayo Clinic

Jennifer M. Matro, MD

Associate Clinical Professor of Medicine, Division of Hematology/Oncology, University of California San Diego Health

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation^®

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare